+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Joint Pain Injections Market - Global Forecast 2026-2032- Product Image
Joint Pain Injections Market - Global Forecast 2026-2032- Product Image
New

Joint Pain Injections Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4905012
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The joint pain injections market is experiencing notable change as innovation in procedures, clinical practice, and outpatient care models redefine core priorities for industry stakeholders.

Market Snapshot: Joint Pain Injections Market Size and Growth Outlook

The joint pain injections market is set for robust expansion, with revenues projected to increase from USD 5.57 billion in 2025 to USD 6.16 billion in 2026, reaching USD 11.85 billion by 2032. An 11.38% compound annual growth rate signals rising adoption, spurred by continued innovation, increasing penetration in outpatient settings, and sustained demand for minimally invasive pain management solutions. This growth reflects the sector’s emphasis on clinical outcomes and rapid technological advancement, attracting keen interest from providers, manufacturers, and payers seeking to optimize patient care, streamline operations, and improve long-term value.

Scope & Segmentation of the Joint Pain Injections Market

  • Molecule Types: The market features corticosteroids, including betamethasone, methylprednisolone acetate, and triamcinolone acetonide. Various hyaluronic acid formulations—both cross-linked and linear—are widely used. Biologic products, such as platelet-rich plasma in both leukocyte-rich and leukocyte-poor variants, play a growing role in clinical protocols.
  • Clinical Indications: Solutions target acute and chronic gout, osteoarthritis by joint location (hip, knee, shoulder), and rheumatoid arthritis categorized by involvement.
  • Route of Administration: Intra-articular injections, including landmark-based and ultrasound-guided techniques, dominate delivery. Intramuscular and peri-articular administration methods expand therapeutic options in varied settings.
  • End-User Settings: Key adoption environments include ambulatory surgical centers, hospitals, and both orthopedic and rheumatology clinics—each with unique workflows, procurement priorities, and operational constraints.
  • Patient Age Groups: Tailored approaches address pediatric, adolescent, adult, and elderly populations, requiring consideration of dosing strategies, safety measures, and recovery timelines across demographics.
  • Global Regions: The market is shaped by varying regional and regulatory dynamics in the Americas, Europe, Middle East & Africa, and Asia-Pacific. Stakeholders must address shifting demographics, manufacturing variances, and local compliance standards.
  • Technological Advances: Image-guided procedures, standardized biologic preparation protocols, and digital monitoring are increasingly embedded in clinical workflow to ensure precise delivery and foster patient engagement post-procedure.

Key Takeaways for Senior Stakeholders

  • Ambulatory surgical centers and outpatient facilities are instrumental in expanding market presence as organizations increasingly shift complex procedures from hospital settings to improve patient accessibility and cost-efficiency.
  • Biologic products, including platelet-rich plasma, are driving a transition in clinical preference away from conventional corticosteroids, resulting in revised procurement processes and evolving therapeutic protocols.
  • Advanced imaging and precision delivery tools, such as ultrasound guidance, are crucial for ensuring consistent patient outcomes and enhancing provider productivity across many care settings.
  • Decision-makers face growing pressure from payers and health systems to demonstrate real-world effectiveness through robust clinical evidence, prompting greater industry investment in outcomes research and long-term data.
  • Integrated solutions aligning product supply, provider education, and digital follow-up have become a norm, helping organizations respond to market shifts while maintaining quality standards and enhancing competitiveness.
  • Rising patient expectations for personalized care and frictionless digital engagement directly influence provider adoption of new technologies and the redesign of service delivery models.

Tariff Impact and Supply Chain Resilience

The introduction of tariffs in 2025 has significantly altered cost structures for raw materials and finished joint pain injection products. Manufacturers and providers are actively diversifying supplier bases, prioritizing regional production facilities, and building buffer inventories to minimize reliance on single sources. Adjusted vendor agreements and a comprehensive approach to supply chain risk management are emerging as core strategies across the sector. Onshoring and cultivating resilient local partnerships are expected to strengthen operational continuity and support compliance across diverse regulatory frameworks.

Methodology & Data Sources

This report utilizes a rigorous, mixed-methods research framework, combining structured interviews with clinicians and supply chain leaders alongside thorough payer analysis. Literature reviews, expert segmentation validation, and cross-referencing with leading clinical registries ensure that outcomes remain data-driven and operationally relevant for industry decision-makers.

Why This Report Matters

  • Equips senior leaders with actionable market intelligence needed to align product offerings, procurement, and clinical strategies with emerging trends and compliance developments.
  • Delivers insights into competitor approaches, regional adoption variations, and evolving payer demands, supporting effective market access and agile operational transformation.
  • Enables more precise strategic planning for manufacturers, providers, and payers seeking to build resilience, maintain regional compliance, and elevate value in a data-driven, patient-focused environment.

Conclusion

Advancements in technology, supply chain strategy, and clinical outcome measurement are shaping the future of the joint pain injections market. Stakeholder collaboration remains vital for delivering consistent, patient-centered results in this evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Joint Pain Injections Market, by Molecule Type
8.1. Corticosteroids
8.1.1. Betamethasone
8.1.2. Methylprednisolone Acetate
8.1.3. Triamcinolone Acetonide
8.2. Hyaluronic Acid
8.2.1. Cross-Linked
8.2.2. Linear
8.3. Platelet-Rich Plasma
8.3.1. Leukocyte-Poor
8.3.2. Leukocyte-Rich
9. Joint Pain Injections Market, by Indication
9.1. Gout
9.1.1. Acute Management
9.1.2. Chronic Management
9.2. Osteoarthritis
9.2.1. Hip
9.2.2. Knee
9.2.3. Shoulder
9.3. Rheumatoid Arthritis
9.3.1. Large Joints
9.3.2. Small Joints
10. Joint Pain Injections Market, by Route Of Administration
10.1. Intra-Articular
10.1.1. Landmark-Based
10.1.2. Ultrasound-Guided
10.2. Intramuscular
10.2.1. Deep Tissue
10.2.2. Superficial
10.3. Peri-Articular
10.3.1. Landmark-Based
10.3.2. Ultrasound-Guided
11. Joint Pain Injections Market, by Patient Age Group
11.1. Adolescents
11.2. Adults
11.3. Elderly
11.4. Pediatrics
12. Joint Pain Injections Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Hospitals
12.3. Orthopedic Clinics
12.4. Rheumatology Clinics
13. Joint Pain Injections Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Joint Pain Injections Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Joint Pain Injections Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Joint Pain Injections Market
17. China Joint Pain Injections Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Anika Therapeutics, Inc.
18.6. Bioventus Inc.
18.7. Chugai Pharmaceutical Co., Ltd.
18.8. Eli Lilly and Company
18.9. Ferring Pharmaceuticals A/S
18.10. Fidia Farmaceutici S.p.A.
18.11. Flexion Therapeutics, Inc.
18.12. Hysingla
18.13. Johnson & Johnson
18.14. Kane Biotech, Inc.
18.15. Lifecore Biomedical, LLC
18.16. OrthogenRx, Inc.
18.17. Pacira BioSciences, Inc.
18.18. Pfizer Inc.
18.19. Regeneron Pharmaceuticals, Inc.
18.20. Sanofi S.A.
18.21. Seikagaku Corporation
18.22. Stryker Corporation
18.23. Teva Pharmaceutical Industries Ltd.
18.24. Zimmer Biomet Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA JOINT PAIN INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY BETAMETHASONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY BETAMETHASONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY BETAMETHASONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE ACETATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE ACETATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY TRIAMCINOLONE ACETONIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY TRIAMCINOLONE ACETONIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY TRIAMCINOLONE ACETONIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CROSS-LINKED, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CROSS-LINKED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CROSS-LINKED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LINEAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LINEAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LINEAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-POOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-POOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-POOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-RICH, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-RICH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LEUKOCYTE-RICH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ACUTE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ACUTE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ACUTE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CHRONIC MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CHRONIC MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CHRONIC MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DEEP TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DEEP TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DEEP TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SUPERFICIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SUPERFICIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SUPERFICIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY LANDMARK-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ULTRASOUND-GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADOLESCENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADOLESCENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 190. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 192. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 193. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 195. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 196. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 198. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 199. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 200. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 201. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 202. EUROPE JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 220. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 221. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 222. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 223. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 224. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 225. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 226. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 227. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 228. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 229. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 230. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 231. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 232. AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 251. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 252. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 253. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 254. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 255. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 256. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 257. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 258. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 259. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 260. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 261. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 262. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 263. ASEAN JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 266. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 267. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 268. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 269. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 270. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 271. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 272. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 273. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 274. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 275. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 276. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 277. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 278. GCC JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 294. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 295. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 296. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 297. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 298. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 299. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 300. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 301. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 302. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 303. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 304. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 305. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 306. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 307. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 308. BRICS JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 309. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 310. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 311. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 312. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID, 2018-2032 (USD MILLION)
TABLE 313. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY PLATELET-RICH PLASMA, 2018-2032 (USD MILLION)
TABLE 314. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 315. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY GOUT, 2018-2032 (USD MILLION)
TABLE 316. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, 2018-2032 (USD MILLION)
TABLE 317. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2032 (USD MILLION)
TABLE 318. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 319. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 320. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, 2018-2032 (USD MILLION)
TABLE 321. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY PERI-ARTICULAR, 2018-2032 (USD MILLION)
TABLE 322. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 323. G7 JOINT PAIN INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 324. NATO JOINT

Companies Mentioned

The key companies profiled in this Joint Pain Injections market report include:
  • Anika Therapeutics, Inc.
  • Bioventus Inc.
  • Chugai Pharmaceutical Co., Ltd.
  • Eli Lilly and Company
  • Ferring Pharmaceuticals A/S
  • Fidia Farmaceutici S.p.A.
  • Flexion Therapeutics, Inc.
  • Hysingla
  • Johnson & Johnson
  • Kane Biotech, Inc.
  • Lifecore Biomedical, LLC
  • OrthogenRx, Inc.
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Seikagaku Corporation
  • Stryker Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.16 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.85 Billion
Compound Annual Growth Rate11.3%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Joint Pain Injections - Global Strategic Business Report - Product Image

Joint Pain Injections - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Joint Pain Injections Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Joint Pain Injections Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Joint Pain Injections Market Report 2025 - Product Image

Joint Pain Injections Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Steroid Injections Market - Global Forecast 2026-2032 - Product Image

Steroid Injections Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From

About the Market

The Joint Pain Injections market is a subset of the Analgesics market, which is focused on providing relief from pain. Joint Pain Injections are used to treat pain caused by arthritis, bursitis, and other joint-related conditions. These injections are typically administered directly into the affected joint, and can provide relief from pain for several weeks or months. The Joint Pain Injections market is composed of a variety of products, including corticosteroids, hyaluronic acid, and platelet-rich plasma. These products are used to reduce inflammation, lubricate the joint, and promote healing. Some of the companies in the Joint Pain Injections market include Pfizer, Sanofi, and Novartis. Other companies include AbbVie, Merck, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.